Concepedia

Sven Hoefman

SH

Statistics

Publications

4

Citations

342

H-Index

4

Active since

2015

Affiliations

Ablynx (Belgium)(Current)

PNO Consultants (Netherlands)

Sven Hoefman is an author at Ablynx (Belgium) specializing in pharmacology, pharmacy, and nanomedicine.

Publications per year

2015–2021

4

Publications

4

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Maarten Van Roy, Cedric Ververken, Els Beirnaert et al. · Arthritis Research & Therapy · 2015 · 179 citations · Full text

, , +14

Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®

Sven Hoefman, Ingrid Ottevaere, Judith Baumeister et al. · Antibodies · 2015 · 118 citations · Full text

, , +13

Population pharmacokinetics of regorafenib in solid tumours: Exposure in clinical practice considering enterohepatic circulation and food intake

Anne Keunecke, Sven Hoefman, Henk‐Jan Drenth et al. · British Journal of Clinical Pharmacology · 2020 · 34 citations · Full text

, , +9

A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP‐1 dual agonist

Rolien Bosch, Marcella Petrone, Rosalin Arends et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 11 citations · Full text

, , +16

1–4 of 4